Lumixyl was developed by researchers at Stanford University Dermatology Department. It is currently the only new type of peptide that can effectively suppress the active of linase enzymes (tyrosinase to promote melanin, which leads to uneven pigment and dark spots. Hydroquinone (HQ), also known as phenylphenol (C_6H_6O_2), is one of the main metabolites of benzene, which plays an important role in the toxic effect of benzene.

Decapeptide-12 (Lumixyl) is a cosmetic raw material that inhibits melanin formation, lightens pigmentation, reduces pigmentation, and evens and brightens skin tone. It was developed by dermatology researchers at Stanford University. A new peptide with tyrosinase (tyrosinase promotes the overproduction of melanin, which leads to uneven pigmentation, dark spots, etc.) activity.